A new source of product development funding has opened up for HIV, TB, and other neglected diseases. The
United Kingdom's Department for International development (DFID) has announced a new $300 million fund for public-private partnerships to develop drugs, vaccines, and other technologies for priority diseases. The fund is open to researchers from any country. Applications for the next round will open in early January, and details will be posted on the DFID website. For more information, to sign up for alerts, or to view the application form for the previous round, visit the DFID website.
< Previous Article | Next Article >